ľ¹ÏÖ±²¥

´¡²Ô²Ô´Ç³Ü²Ô³¦±ð³¾±ð²Ô³Ù²õÌý

Dr. Collins provided summaries of several Congressional visits, meetings, and hearings. An overview of recent antimicrobial resistance (AMR) activities, including the NIH-FDA Leadership Council also was described.  

Sub-IC BRAIN Group: Kathy Hudson

Dr. Hudson (DDSOP) described the composition of the Sub-IC BRAIN group and the steps going forward.

Potential Common Fund (CF) Topics: Jim Anderson

Dr. Anderson (DPCPSI) presented a summary of four potential Common Fund topics for consideration, including glycoscience. The discussion focused on particular scientific aspects of each topic, concerns, and integration across the ICs.